This drug repurposing, or polypharmacology, is becoming more and more prevalent, as the one target one drug paradigm that started ~20yrs ago has resulted in less successful drugs, than these multitarget drugs based on phenotypic response (as opposed to merely genotypic knockouts). Another example is Viagra, originially purposed to lower blood pressure haha.
Had to write an essay on the "Polypharmacology on Neurological diseases: Toward 21st century treatments" for my Chemistry Honours. A lot of interesting papers on the topic.
Makes me think the HIIT platform could be a real hit if DXB is able to diversify after focusing on DMX and gaining revenue. A lot of potential in DMX, but IMO the HIIT platform could mean many many more DMX style opportunities in the future.
- Forums
- ASX - By Stock
- DXB will come good – Here’s why
This drug repurposing, or polypharmacology, is becoming more and...
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
52.5¢ |
Change
0.015(2.94%) |
Mkt cap ! $286.1M |
Open | High | Low | Value | Volume |
51.5¢ | 54.5¢ | 51.0¢ | $1.171M | 2.252M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 119083 | 52.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
52.5¢ | 39503 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 119083 | 0.520 |
8 | 152490 | 0.515 |
12 | 492960 | 0.510 |
10 | 1045075 | 0.505 |
16 | 403506 | 0.500 |
Price($) | Vol. | No. |
---|---|---|
0.525 | 39503 | 3 |
0.530 | 83803 | 3 |
0.535 | 48283 | 4 |
0.540 | 246028 | 6 |
0.545 | 75916 | 6 |
Last trade - 13.22pm 28/06/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online